Paid Clinical Trials Augusta

Discover 233 paid clinical trials in Augusta, Georgia. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 233

Chemotherapy with Endocrine TherapyEvaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

Recruiting

PHASE3

Sponsor:

NRG Oncology

Location:

Augusta GA, Union SC, Spartanburg SC, Greer SCshow 715 more

Code:

NCT05879926

Conditions

Breast Cancer

Eligibility Criteria

Sex: Female

Age: 18 - 60

Healthy Volunteers: Not accepted

Interventions

Ovarian Function Suppression + Aromatase Inhibitor

Adjuvant Chemotherapy + Ovarian Function Suppression

Cardiovascular InterventionA RAndomizeD Intervention for Cardiovascular and Lifestyle Risk Factors in Prostate Cancer Patients

Recruiting

Sponsor:

McMaster University

Location:

Augusta GA, London, Hamilton, Kitchenershow 9 more

Code:

NCT03127631

Conditions

Prostate Cancer

Cardiovascular Disease

Eligibility Criteria

Sex: Male

Age: 45+

Healthy Volunteers: Not accepted

Interventions

Nutrition

Exercise

Smoking cessation

Statin (such as Simvastatin, Atorvastatin, Rosuvastatin, Pravastatin)

ACE inhibitor

RGLS8429A Study of RGLS8429 in Patients With Autosomal Dominant Polycystic Kidney Disease

Recruiting

PHASE1

Sponsor:

Regulus Therapeutics Inc.

Location:

Augusta GA, Jacksonville FL, Orlando FL, Baltimore MDshow 23 more

Code:

NCT05521191

Conditions

Autosomal Dominant Polycystic Kidney Disease

ADPKD

Polycystic Kidney, Autosomal Dominant

Eligibility Criteria

Sex: All

Age: 18 - 70

Healthy Volunteers: Not accepted

Interventions

RGLS8429

Placebo

SelinexorSelinexor in Maintenance Therapy After Systemic Therapy for Participants With p53 Wild-Type, Advanced or Recurrent Endometrial Carcinoma

Recruiting

PHASE3

Sponsor:

Karyopharm Therapeutics Inc

Location:

Augusta GA, Gainesville GA, Charlotte NC, Atlanta GAshow 71 more

Code:

NCT05611931

Conditions

Endometrial Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Selinexor

Matching Placebo for selinexor

DonanemabA Donanemab (LY3002813) Study in Participants With Preclinical Alzheimer's Disease (TRAILBLAZER-ALZ 3)

Recruiting

PHASE3

Sponsor:

Eli Lilly and Company

Location:

Augusta GA, Columbia SC, Anderson SC, Union SCshow 172 more

Code:

NCT05026866

Conditions

Alzheimer Disease

Eligibility Criteria

Sex: All

Age: 65 - 70+

Healthy Volunteers: Not accepted

Interventions

Donanemab

Placebo

EtavopivatA Research Study Looking at Long-term Treatment With Etavopivat in People With Sickle Cell Disease or Thalassaemia

Recruiting

PHASE3

Sponsor:

Novo Nordisk A/S

Location:

Augusta GA, Greenville SC, Charleston SC, Atlanta GAshow 28 more

Code:

NCT06609226

Conditions

Sickle Cell Disease, Thalassemia

Eligibility Criteria

Sex: All

Age: 0 - 70+

Healthy Volunteers: Not accepted

Interventions

Etavopivat A

Etavopivat B

Sacituzumab vs. TreatmentA Study to Compare Sacituzumab Tirumotecan (MK-2870) Monotherapy Versus Treatment of Physician's Choice as Second-line Treatment for Participants With Recurrent or Metastatic Cervical Cancer (MK-2870-020/TroFuse-020/Gog-3101/ENGOT-cx20)

Recruiting

PHASE3

Sponsor:

Merck Sharp & Dohme LLC

Location:

Augusta GA, Savannah GA, Atlanta GA, Durham NCshow 32 more

Code:

NCT06459180

Conditions

Cervical Cancer

Eligibility Criteria

Sex: Female

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Sacituzumab Tirumotecan

Pemetrexed

Tisotumab Vedotin

Topotecan

Vinorelbine

Enhanced RecoveryCompliance With Enhanced Recovery After Surgery Protocol (ERAS) in Surgical Patients

Recruiting

Sponsor:

Augusta University

Location:

Augusta GA

Code:

NCT03968666

Conditions

Surgery

Anesthesia

Eligibility Criteria

Sex: Female

Age: 18+

Healthy Volunteers: Not accepted

ALXN2220Study of ALXN2220 Versus Placebo in Adults With ATTR-CM

Recruiting

PHASE3

Sponsor:

Alexion Pharmaceuticals, Inc.

Location:

Augusta GA, Greenville SC, Charleston SC, Atlanta GAshow 44 more

Code:

NCT06183931

Conditions

Transthyretin Amyloid Cardiomyopathy

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

ALXN2220

Placebo

TX000045A Study of TX000045 in Patients With Pulmonary Hypertension Secondary to Heart Failure With Preserved Ejection Fraction (the APEX Study)

Recruiting

PHASE2

Sponsor:

Tectonic Therapeutic

Location:

Augusta GA, Rock Hill SC, McDonough GA, Jacksonville FLshow 21 more

Code:

NCT06616974

Conditions

Pulmonary Hypertension

Heart Failure With Preserved Ejection Fraction

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

TX000045- Dose A

TX000045- Dose B

Placebo